Akebia Therapeutics
AKBA
#9606
Rank
โ‚ฌ97.57 M
Marketcap
0,35ย โ‚ฌ
Share price
-8.71%
Change (1 day)
-74.51%
Change (1 year)

Akebia Therapeutics (AKBA) - Total debt

Total debt on the balance sheet as of June 2026 : โ‚ฌ50.1 Million

According to Akebia Therapeutics's latest financial reports the company's total debt is โ‚ฌ50.1 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Akebia Therapeutics - Total debt on balance sheet (from 2013 to 2026)

Total debt by year

Year Total debt Change
2025-12-31โ‚ฌ44.09 M-3.69%
2024-12-31โ‚ฌ45.78 M5.17%
2023-12-31โ‚ฌ43.53 M-53.2%
2022-12-31โ‚ฌ93.02 M-22.57%
2021-12-31โ‚ฌ0.12 B17%
2020-12-31โ‚ฌ0.10 B6.18%
2019-12-31โ‚ฌ96.69 M637.47%
2018-12-31โ‚ฌ13.11 M
2013-12-31โ‚ฌ0 M
2012-12-31N/A

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ40.70 B 81,129.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ44.03 B 87,785.90%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
โ‚ฌ52.23 B 104,147.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
โ‚ฌ71.61 M 42.91%๐Ÿ‡บ๐Ÿ‡ธ USA